Last reviewed · How we verify
Hearing Aid with NR_4 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Hearing Aid with NR_4 (Hearing Aid with NR_4) — Sonova AG.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Hearing Aid with NR_4 TARGET | Hearing Aid with NR_4 | Sonova AG | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Hearing Aid with NR_4 CI watch — RSS
- Hearing Aid with NR_4 CI watch — Atom
- Hearing Aid with NR_4 CI watch — JSON
- Hearing Aid with NR_4 alone — RSS
Cite this brief
Drug Landscape (2026). Hearing Aid with NR_4 — Competitive Intelligence Brief. https://druglandscape.com/ci/hearing-aid-with-nr-4. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab